openPR Logo
Press release

Zopiclone Market Overall Study Report 2021-2028 | Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc.

10-28-2021 03:15 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Zopiclone

Zopiclone

Global Zopiclone market analysis

Overview

Zopiclone is a cyclopyrrolone that belongs to the class of psychotherapeutic agents used to cure insomnia. It is sold as a tablet. It works as an amino butyric acid agonist, causing signal propagation through nerves in the brain to be blocked. As a result, zopiclone has a soothing effect on the user, which increases the sleep period.

Zopiclone has myorelaxant, anxiolytic, and anticonvulsant properties in addition to its hypnotic effect. Zopiclone is readily ingested after a single oral dosage, with a bioavailability of about 80%, and spread to salivary glands, brain tissues, breast milk, and the placenta. Zopiclone is metabolised extensively and excreted in breast milk, vomit, and saliva (about five hour excretion life.). Drugs are available from companies including Hikma Pharmaceuticals PLC, Sumitomo Dainippon Pharma Co. Ltd., Glenmark Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., and others.

To Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/3385

Drivers

Leading manufacturers are concentrating on zopiclone production, which is expected to help the global zopiclone market expand. Since the patent on the name (zopiclone) expired in 2014, several companies released generic versions of the drug. Generic has been launched in the U.S. by companies including Mylan and Dr. Reddys Laboratories. Furthermore, according to an article released in October 2018 by the non-profit organisation Best Practice Advocacy Centre New Zealand, New Zealand is the biggest consumer of prescription hypnotic medication, with zopiclone being the most often prescribed hypnotic.

The same source also revealed the following statistics to reflect the number of patients suffering from insomnia per 1,000 people in New Zealand in 2017: under 25 years old (3.2 patients), 26–35 years old (18.9 patients), 36–45 years old (30.4 patients), 46–55 years old (45.6 patients), 56–65 years old (60.7 patients), and over 65 years (86.9 patients).

In Asia Pacific, the prevalence of insomnia is smaller than in Europe and North America. As per the NCBI (National Center for Biotechnology Information), the geriatric community experiences insomnia, as well as other mental illnesses such as depression, anxiety, and post-traumatic stress disorder in 2019. Comorbid health conditions such as GERD (gastroesophageal reflux disease), restless leg syndrome, persistent pain and respiratory problems, as well as alcohol or drug dependence, may also lead to insomnia, according to the same report.

Restraints

During the forecast period, the following factors are expected to limit the global zopiclone market's growth. Manufacturers' introduction of alternate therapeutic solutions for insomnia, such as new medications and gadgets, is likely to slow the development of the zopiclone tablets sector. Cervella Cranial Electrotherapy Stimulator, a non-drug based alternative medication for anxiety, depression, and insomnia, obtained FDA approval in March 2019 from Innovative Neurological Devices LLC. Ramelteon, a new generic insomnia treatment introduced by Dr. Reddy's Laboratories in July 2019, was also approved by the US FDA. The medication belongs to the melatonin receptor agonist family, whereas zopiclone belongs to the GABA receptor agonist class.

For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/3385

Regional Analysis

Due to the high presence of key players in North America, the region is expected to maintain a leading role in the global zopiclone market over the forecast period. Furthermore, the rising prevalence of insomnia in North America and Europe is projected to boost business demand. As per PLOS One, about 27.1 percent of people in the U.S. and 37.2 percent of people in France and Italy suffer from insomnia in 2017.

The same source added that about 5% of people in China, 15.3 percent of people in Japan, and 17.3 percent of people in Singapore suffer from insomnia in the Asia Pacific region. During the forecast period, these factors are expected to fuel the Asia Pacific zopiclone market growth.

Key Players

Major companies contributing in the global zopiclone market include Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., AvKARE Inc., Macleods Pharmaceuticals Ltd., Sumitomo Dainippon Pharma Co. Ltd., Hikma Pharmaceuticals PLC, and Sun Pharma Pharmaceutical Industries Ltd.

To Direct Purchase this Premium Research Report – https://www.coherentmarketinsights.com/insight/buy-now/3385

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Zopiclone Market Overall Study Report 2021-2028 | Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc. here

News-ID: 2446582 • Views: 394

More Releases from Coherent Market Insights

Prepacked Chromatography Columns Market Detailed In New Research Report 2021 | A …
Global Prepacked Chromatography Columns market Overview Single-use innovations make manufacturing simpler with prepackaged chromatography columns. Equipment capital and qualification, asset traceability, calibration, and routine maintenance are all eliminated with these columns. Prepackaged chromatography columns often save money on materials and consumables associated with column packing. Statistics By the end of 2027, the global prepacked chromatography columns market is expected to be worth US$ 4,263.5 million. Drivers Increased investment in regenerative medicine research and development is
Urinary Catheters Market See Incredible Growth 2021-2028 | Braun Melsungen AG, C …
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
Electrophysiology Devices Market Expected to Expand at a Steady 2021-2028 | GE H …
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
Acute Otitis Media Treatment Market See Incredible Growth 2021-2028 | Pfizer, In …
Global Acute Otitis Media Treatment Market The Global Acute Otitis Media Treatment Market, By Drug Type (Anesthetic, Analgesic, Antibiotics, and Non-steroidal anti-Inflammatory Drug), By Formulation (Topical and Oral), By Distribution Channel (Online Pharmacies, Hospitals, and Retail Pharmacies), and by Region (North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa) had a market valuation of US$ 2,043.3 million in 2016 and is anticipated to grow at a CAGR of

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business